John Y. L. Chung,Yanfeng Zhang,Laura Artino,Jennifer Baxter,Aaron S. Cote,Yekaterina Vaynshteyn,Donal Desmond,Jeremy Scott
申请号：
US13144031
公开号：
US08697740B2
申请日:
2010.01.08
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to polymorphic forms of a compound of formula A: This compound is useful as a glucagon receptor antagonist and serves as a pharmaceutically active ingredient for the treatment of type 2 diabetes and related conditions, such as hyperglycemia, obesity, dyslipidemia, and the metabolic syndrome. Hydrates, hemihydrates, anhydrates and similar polymorphic forms are included.
